Efficacy of Suhuang zhike capsule in patients with cough variant asthma
XIONG Ning
PENG Zhi-qun
WU Jin-fei
WANG Qiang
CHEN Chuan-lin
WU Shan-yan
Abstract：Objective To observe the clinical efficacy of Suhuang zhike capsule in treatment of cough variant asthma(CVA).Methods The CVA patients were randomly divided into Suhuang zhike capsule group and bricanyl group(40 cases in each group).Suhuang zhike capsule group were treated with Suhuang zhike capsule.Bricanyl group were treated with bricanyl.Two groups were treated for 4 weeks.Results The cure rate of Suhuang zhike capsule group and bricanyl group was 92.5％ (37/40),72.5％ (29/40),and there was a significant difference (P ＜ 0.05).The serum total IgG in Suhuang zhike capsule group after treatment was (8.8 ± 4.7)g/L,which was higher than that before treatment [(6.4 ± 3.2) g/L,P ＜ 0.05].The serum total IgG in bricanyl group after treatment was (7.2 ± 3.8) g/L,which was higher than that before treatment [(6.5 ± 2.9) g/L,P ＜ 0.05].The airway resistance in Suhuang zhike capsule group postoperation were lower than those in bricanyl group after treatment [(122 ±36)cm H2O (1 cm H2O =0.098 kPa) vs (144±41)cm H2O,(118 ±32)cm H2O vs(142 ±35)cm H2O,(83 ± 26)cm H2O vs (100 ± 24)cm H2O; all P ＜ 0.01].Conclusion Suhuang zhike capsule has a good effect on patients with CVA.
Keywords：Suhuang zhike capsuleCough variant asthmaAirway hyperresponsiveness
Publication Date：2013-08-30
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：2( 1071-1072 )